Transsexualism

The document from 2012 outlines the condition of transsexualism, where an individual's gender identity does not align with their physical sex, leading to significant distress. It describes the treatment process, which includes psychiatric evaluation, counseling, hormone therapy, and sex reassignment surgery, with a prerequisite real-life experience of one year before irreversible procedures. The prevalence of transsexualism is estimated to be between 1/3,000 and 1/30,000, with the gap between male-to-female and female-to-male transitions narrowing. Biological factors are suggested as the cause, with no evidence for social or psychological origins. Hormone treatments are considered safe and aim to develop secondary sex characteristics of the desired sex. The document reports improved quality of life post-transition but acknowledges increased mortality and morbidity rates, including higher incidences of psychiatric issues and mortality from suicide and cardiovascular disease. It emphasizes the importance of medical monitoring and ongoing support for transsexual individuals after treatment.